|
|
|
|
|
00000cam0a22000004ib4500 |
| 001 |
BY-NLB-br66911 |
| 005 |
20070615181510.8 |
| 010 |
# |
# |
$d 2000 r.
|
| 100 |
# |
# |
$a 19940530d1995 u y0rusy50 ca
|
| 101 |
0 |
# |
$a eng
|
| 102 |
# |
# |
$a ru
|
| 105 |
# |
# |
$a y 000yy
|
| 109 |
# |
# |
$a aa
|
| 200 |
1 |
# |
$a Neutrondefficient nuclides for positron emission tomography. XIII. Production of 83 Sr for in vivo dosimetry
|
| 210 |
# |
# |
$a Moscow
$d 1995
|
| 215 |
# |
# |
$a 6 p.
|
| 225 |
1 |
# |
$a Prepr.
$f ITEP
$v 3-95)
|
| 300 |
# |
# |
$a Ref.:p.5-6
|
| 345 |
# |
# |
$9 114 экз.
|
| 606 |
0 |
# |
$3 BY-NLB-ar39382
$a ЭМИССИЯ (физ.)
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar21047
$a НУКЛИДЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar32332
$a РАДИОАКТИВНЫЙ СТРОНЦИЙ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar24233
$a ПОЗИТРОНЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar9667
$a ДОЗИМЕТРИЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar2743697
$a ИСПОЛЬЗОВАНИЕ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar33534
$a ТЕРАПИЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar34148
$a ТАМАГРАФІЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar39383
$a ЭМІСІЯ (фіз.)
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar21048
$a НУКЛІДЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar32333
$a РАДЫЕАКТЫЎНЫ СТРОНЦЫЙ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar24234
$a ПАЗІТРОНЫ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar9668
$a ДАЗІМЕТРЫЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar2743699
$a ВЫКАРЫСТАННЕ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar33535
$a ТЭРАПІЯ
$2 DVNLB
|
| 606 |
0 |
# |
$3 BY-NLB-ar34147
$a ТОМОГРАФИЯ
$2 DVNLB
|
| 675 |
# |
# |
$a 539.163:519.674
$v 3
$z rus
|
| 675 |
# |
# |
$a 616-073.756.8
$v 3
$z rus
|
| 686 |
# |
# |
$a 29.15.15
$2 rugasnti
|
| 686 |
# |
# |
$a 34.49.33
$2 rugasnti
|
| 686 |
# |
# |
$a 76.13.25
$2 rugasnti
|
| 700 |
# |
1 |
$3 BY-SEK-265600
$a Tolmachev
$b V.
|
| 701 |
# |
1 |
$3 BY-SEK-265602
$a Lundqvist
$b H.
|
| 801 |
# |
0 |
$a BY
$b BY-HM0000
$c 19940530
$g psbo
|
| 801 |
# |
1 |
$a BY
$b BY-HM0000
$c 20060315
$g psbo
|
